215 related articles for article (PubMed ID: 27160664)
1. Nanoparticle-Mediated Mitochondrial Damage Induces Apoptosis in Cancer.
Mallick A; More P; Syed MM; Basu S
ACS Appl Mater Interfaces; 2016 Jun; 8(21):13218-31. PubMed ID: 27160664
[TBL] [Abstract][Full Text] [Related]
2. Tumor- and mitochondria-targeted nanoparticles eradicate drug resistant lung cancer through mitochondrial pathway of apoptosis.
Wang H; Zhang F; Wen H; Shi W; Huang Q; Huang Y; Xie J; Li P; Chen J; Qin L; Zhou Y
J Nanobiotechnology; 2020 Jan; 18(1):8. PubMed ID: 31918714
[TBL] [Abstract][Full Text] [Related]
3. Synergistic antitumor efficacy of hybrid micelles with mitochondrial targeting and stimuli-responsive drug release behavior.
Chen Z; Zhang Z; Chen M; Xie S; Wang T; Li X
J Mater Chem B; 2019 Mar; 7(9):1415-1426. PubMed ID: 32255012
[TBL] [Abstract][Full Text] [Related]
4. Tocopheramine succinate and tocopheryl succinate: mechanism of mitochondrial inhibition and superoxide radical production.
Gruber J; Staniek K; Krewenka C; Moldzio R; Patel A; Böhmdorfer S; Rosenau T; Gille L
Bioorg Med Chem; 2014 Jan; 22(2):684-91. PubMed ID: 24393721
[TBL] [Abstract][Full Text] [Related]
5. Anticancer Effect of α-Tocopheryl Succinate Delivered by Mitochondria-Targeted Mesoporous Silica Nanoparticles.
Qu Q; Ma X; Zhao Y
ACS Appl Mater Interfaces; 2016 Dec; 8(50):34261-34269. PubMed ID: 27998109
[TBL] [Abstract][Full Text] [Related]
6. Nanoemulsion enhances α-tocopherol succinate bioavailability in rats.
Gao Y; Qi X; Zheng Y; Ji H; Wu L; Zheng N; Tang J
Int J Pharm; 2016 Dec; 515(1-2):506-514. PubMed ID: 27746330
[TBL] [Abstract][Full Text] [Related]
7. Contrasting effects of α-tocopheryl succinate on cisplatin- and etoposide-induced apoptosis.
Kruspig B; Zhivotovsky B; Gogvadze V
Mitochondrion; 2013 Sep; 13(5):533-8. PubMed ID: 22971517
[TBL] [Abstract][Full Text] [Related]
8. alpha-Tocopheryl succinate causes mitochondrial permeabilization by preferential formation of Bak channels.
Prochazka L; Dong LF; Valis K; Freeman R; Ralph SJ; Turanek J; Neuzil J
Apoptosis; 2010 Jul; 15(7):782-94. PubMed ID: 20217235
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrially Targeted Nanoparticles Based on α-TOS for the Selective Cancer Treatment.
Palao-Suay R; Rodrigáñez L; Aguilar MR; Sánchez-Rodríguez C; Parra F; Fernández M; Parra J; Riestra-Ayora J; Sanz-Fernández R; San Román J
Macromol Biosci; 2016 Mar; 16(3):395-411. PubMed ID: 26632009
[TBL] [Abstract][Full Text] [Related]
10. α-Tocopheryl Succinate-Based Polymeric Nanoparticles for the Treatment of Head and Neck Squamous Cell Carcinoma.
Sánchez-Rodríguez C; Palao-Suay R; Rodrigáñez L; Aguilar MR; Martín-Saldaña S; San Román J; Sanz-Fernández R
Biomolecules; 2018 Sep; 8(3):. PubMed ID: 30235821
[TBL] [Abstract][Full Text] [Related]
11. Biotin-conjugated PEGylated porphyrin self-assembled nanoparticles co-targeting mitochondria and lysosomes for advanced chemo-photodynamic combination therapy.
Purushothaman B; Choi J; Park S; Lee J; Samson AAS; Hong S; Song JM
J Mater Chem B; 2019 Jan; 7(1):65-79. PubMed ID: 32254951
[TBL] [Abstract][Full Text] [Related]
12. Targeted delivery of geranylgeranylacetone to mitochondria by triphenylphosphonium modified nanoparticles: a promising strategy to prevent aminoglycoside-induced hearing loss.
Wang Z; Kuang X; Shi J; Guo W; Liu H
Biomater Sci; 2017 Aug; 5(9):1800-1809. PubMed ID: 28650045
[TBL] [Abstract][Full Text] [Related]
13. Co-delivery nanocarriers targeting folate receptor and encapsulating 2-deoxyglucose and α-tocopheryl succinate enhance anti-tumor effect in vivo.
Lei X; Li K; Liu Y; Wang ZY; Ruan BJ; Wang L; Xiang A; Wu D; Lu Z
Int J Nanomedicine; 2017; 12():5701-5715. PubMed ID: 28848348
[TBL] [Abstract][Full Text] [Related]
14. Mitochondria Targeting and Destabilizing Hyaluronic Acid Derivative-Based Nanoparticles for the Delivery of Lapatinib to Triple-Negative Breast Cancer.
Lee SY; Cho HJ
Biomacromolecules; 2019 Feb; 20(2):835-845. PubMed ID: 30566834
[TBL] [Abstract][Full Text] [Related]
15. Bid integrates intrinsic and extrinsic signaling in apoptosis induced by alpha-tocopheryl succinate in human gastric carcinoma cells.
Zhao Y; Li R; Xia W; Neuzil J; Lu Y; Zhang H; Zhao X; Zhang X; Sun C; Wu K
Cancer Lett; 2010 Feb; 288(1):42-9. PubMed ID: 19640637
[TBL] [Abstract][Full Text] [Related]
16. Triphenylphosphine-docetaxel conjugate-incorporated albumin nanoparticles for cancer treatment.
Battogtokh G; Gotov O; Kang JH; Cho J; Jeong TH; Chimed G; Ko YT
Nanomedicine (Lond); 2018 Feb; 13(3):325-338. PubMed ID: 29338573
[TBL] [Abstract][Full Text] [Related]
17. The role of alpha tocopheryl succinate (α-TOS) as a potential anticancer agent.
Angulo-Molina A; Reyes-Leyva J; López-Malo A; Hernández J
Nutr Cancer; 2014; 66(2):167-76. PubMed ID: 24364743
[TBL] [Abstract][Full Text] [Related]
18. (+)α-Tocopheryl succinate inhibits the mitochondrial respiratory chain complex I and is as effective as arsenic trioxide or ATRA against acute promyelocytic leukemia in vivo.
dos Santos GA; Abreu e Lima RS; Pestana CR; Lima AS; Scheucher PS; Thomé CH; Gimenes-Teixeira HL; Santana-Lemos BA; Lucena-Araujo AR; Rodrigues FP; Nasr R; Uyemura SA; Falcão RP; de Thé H; Pandolfi PP; Curti C; Rego EM
Leukemia; 2012 Mar; 26(3):451-60. PubMed ID: 21869839
[TBL] [Abstract][Full Text] [Related]
19. Preparation and antitumor activity of triphenylphosphine-based mitochondrial targeting polylactic acid nanoparticles loaded with 7-hydroxyl coumarin.
Ye L; Yao Q; Xu F; He L; Ding J; Xiao R; Ding L; Luo B
J Biomater Appl; 2022 Jan; 36(6):1064-1075. PubMed ID: 34338057
[TBL] [Abstract][Full Text] [Related]
20. Photosensitizer-mediated mitochondria-targeting nanosized drug carriers: Subcellular targeting, therapeutic, and imaging potentials.
Choi YS; Kwon K; Yoon K; Huh KM; Kang HC
Int J Pharm; 2017 Mar; 520(1-2):195-206. PubMed ID: 28179191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
